Kemal Malik

Insider profile

Currently holds a position at Acceleron Pharma Inc

Performance

Overall performance
0.6

Performance over holding periods
0.6
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Acceleron Pharma Inc Jan. 1, 2020 -
Member of the Management Board, Innovation and the Latin America Region Bayer AG Feb. 1, 2014 - Dec. 31, 2019

Kemal Malik's trades of Syncona Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
296.32
Quantity 9,895
Value £4,940,768
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-03-30 2021-03-26 B Purchase
9,895
296.32
£4,940,768
9,895 296.32 £4,940,768